Collard Craig A bought HRTX
April 30, 2026 · Form 4 insider transaction
Collard Craig A bought 50,021 shares of Heron Therapeutics, Inc., a transaction worth N/A. The trade was recorded as option exercise and disclosed on an SEC Form 4, filed 4 days after the transaction.
Direction
Acquired (buy-side)
Shares
50,021
Price
N/A
Total value
N/A
InsiderCollard Craig A
RoleOfficer, Director
SecurityCommon Stock
Transaction codeM: Option exercise
Transaction dateApril 30, 2026
Filing dateMay 4, 2026
Shares owned after757,885
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
Each restricted stock unit represents a contingent right to receive one share of common stock.; Includes 11,023 shares acquired under the Heron Therapeutics, Inc. 1997 Employee Stock Purchase Plan on April 30, 2026.